In an adult with symptomatic hydrocephalus, headache, ventricular enlargement on CT, and an acellular cerebrospinal fluid sample, is tuberculous meningitis the likely diagnosis?

Tuberculous Meningitis is Unlikely but Cannot Be Definitively Excluded

An acellular CSF sample makes tuberculous meningitis (TBM) unlikely, but this presentation does not completely rule it out, and further diagnostic evaluation is warranted given the high mortality risk of untreated TBM.

Key Diagnostic Considerations

CSF Profile in Tuberculous Meningitis

The typical CSF findings in TBM include 1, 2, 3:

• Lymphocytic pleocytosis (tens to hundreds of cells)
• Elevated protein (commonly >150 mg/dL)
• Low glucose (less than half to two-thirds of blood glucose)
• Elevated opening pressure

However, acellular CSF can occur in TBM, particularly:

• Early in the disease course 4
• In immunocompromised patients 4
• When ventricular CSF is sampled instead of lumbar CSF 5

Critical Pitfall: Ventricular vs. Lumbar CSF

If your CSF sample was obtained from a ventricular drain or shunt (given the hydrocephalus), this is a major diagnostic pitfall. Ventricular CSF may be normal even when tuberculous meningitis is present 5. The pathophysiology involves:

• Basilar meningeal inflammation predominantly affecting lumbar subarachnoid space
• Inflammatory cells and organisms concentrated in basal cisterns
• Ventricular fluid may not reflect the inflammatory process

Recommendation: Obtain lumbar CSF if only ventricular fluid was initially sampled 5. This is essential even with normal ventricular CSF results when TBM is suspected.

Hydrocephalus as a Key Feature

Hydrocephalus occurs in approximately 65% of TBM patients and is one of the most common complications 6. The combination of:

• Symptomatic hydrocephalus
• Ventricular enlargement on CT
• Headache

...creates a clinical picture highly compatible with TBM 6, 7, even with initially normal CSF.

Diagnostic Algorithm

Immediate Actions:

1. Determine CSF source: Was this ventricular or lumbar fluid?

   • If ventricular only → perform lumbar puncture (unless contraindicated) 5
   • Expect lumbar CSF to show pleocytosis even when ventricular CSF is normal

2. Repeat CSF analysis within 24-48 hours if initial sample was acellular 4

   • In HSV encephalitis (similar principle), 5-10% have normal initial CSF but abnormal repeat sampling
   • TBM can present similarly with delayed CSF changes

3. Send comprehensive CSF studies 8:

   • Mycobacterial culture (gold standard, though sensitivity only 25% in adults)
   • NAAT/PCR for M. tuberculosis (sensitivity 62% for CSF, specificity 98%)
   • Serial samples increase diagnostic yield
   • Smear for acid-fast bacilli (low sensitivity but rapid)

4. Obtain contrast-enhanced MRI brain 1, 2:

   • Look for basilar meningeal enhancement (strongly suggestive)
   • Basal exudates (significant predictor of TBM)
   • Vasculitic infarcts in basal ganglia
   • Tuberculomas
   • The combination of meningeal enhancement + any degree of hydrocephalus is strongly suggestive of TBM 9

Risk Stratification:

High-risk features for TBM include 2, 3, 6:

• HIV infection or other immunosuppression
• TB-endemic country origin
• Known TB exposure or active pulmonary TB
• Subacute presentation (weeks of symptoms)
• Cranial nerve palsies
• Focal neurologic deficits
• Visual impairment
• Basal exudates on imaging

Treatment Decision

If clinical suspicion remains high despite acellular CSF:

Empiric anti-tuberculous therapy should be initiated promptly without waiting for microbiological confirmation 1, 2. TBM mortality is exceptionally high when treatment is delayed, and early treatment is the most critical determinant of outcome 2, 3.

Standard regimen 1:

• Initial phase (2 months): Isoniazid + Rifampin + Pyrazinamide + Ethambutol
• Continuation phase (7-10 months): Isoniazid + Rifampin
• Total duration: 9-12 months (longer than pulmonary TB)

Add adjunctive dexamethasone or prednisolone tapered over 6-8 weeks 1 - this has demonstrated mortality benefit in TBM (strong recommendation, moderate certainty evidence).

Hydrocephalus Management:

• Monitor intracranial pressure with serial lumbar punctures 1
• Early neurosurgical consultation for potential VP shunt placement 1, 9
• Hydrocephalus occurs in two-thirds of TBM patients and significantly impacts mortality 6, 7

Alternative Diagnoses to Consider

With acellular CSF and hydrocephalus, also evaluate for:

• Coccidioidomycosis meningitis (if endemic exposure) - can present with normal CSF initially 9
• Cryptococcal meningitis (especially if immunocompromised)
• Partially treated bacterial meningitis 4
• Viral meningitis (though typically shows pleocytosis) 4
• Aseptic meningitis with obstructive hydrocephalus 10

Bottom Line

Acellular CSF makes TBM less likely but does not exclude it, particularly if ventricular fluid was sampled or if this represents very early disease. The presence of symptomatic hydrocephalus with ventricular enlargement is a common TBM complication. Obtain lumbar CSF if not already done, repeat sampling in 24-48 hours, perform contrast MRI, and strongly consider empiric anti-tuberculous therapy if clinical suspicion remains high - the consequences of delayed treatment far outweigh the risks of empiric therapy given TBM's near-universal fatality when untreated 2, 3.